Do you still get hungry on Wegovy — and what should you expect?

Wegovy (semaglutide) reduces appetite through GLP-1 receptor signalling in the brain and gut, it doesn't simply suppress hunger by willpower, it changes the biology behind it.
Hunger reduction tends to build with each dose increase; many people notice the biggest shift between the 1.0mg and 1.7mg steps.
Some people experience a temporary increase in appetite when transitioning between doses, this is normal and usually brief.
Emotional eating and food cravings are separate from physical hunger, and Wegovy may affect them differently, some people find cravings fade more than stomach hunger does.

Most people taking Wegovy notice a real reduction in hunger, but it rarely disappears entirely. Semaglutide works partly by slowing how quickly your stomach empties and by acting on appetite-regulating centres in the brain, which means meals feel filling sooner and the urge to eat between them tends to quieten. That said, hunger doesn't vanish overnight, it shifts — and for some people at certain doses it barely shifts at all, at least not yet. These are prescription-only medicines, and a prescriber assesses whether they're right for you before anything is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why hunger behaves differently on Wegovy, and what to do about it

The first few weeks: hunger doesn't always go quietly

Imagine it's three weeks in. Your pen arrived in an unbranded box, DPD tracking on your phone, and you've done your second injection. You expected hunger to disappear. Instead you're still thinking about lunch at 11am and wondering if something's wrong.

Nothing is. At the 0.25mg starting dose, semaglutide is doing a settling-in job, your system is adjusting to the medicine, and the appetite effects at that level are modest for most people. The full picture of how Wegovy works involves a gradual build: GLP-1 receptors in the hypothalamus and gut are being progressively activated, and that process takes the titration steps to really land.

Most people describe the change not as hunger vanishing but as a softening. The sharp, urgent feeling (the kind that makes you clock-watch until dinner) dulls. You still notice hunger, but it stops running the show. That's a meaningful shift, even if it doesn't feel dramatic at first.

According to NHS guidance on semaglutide, the most common early side effects are gastrointestinal (nausea, constipation, indigestion) and these can themselves suppress appetite temporarily. So in weeks one to four, reduced eating and reduced hunger are sometimes two different things happening for different reasons.

Why some people still feel hungry at higher doses

Here's the honest part: not everyone gets dramatic appetite suppression, even at 2.4mg maintenance. If you want a closer look at why some people find themselves hungry on Wegovy, the pattern is more common than most expect, with a portion of people on semaglutide reporting that physical stomach hunger remains present, while others find their relationship with food changes in subtler ways, less fixation, smaller portions feeling satisfying, less drive to finish a plate.

One reason is that hunger has layers. There's physiological hunger (low blood sugar, an empty stomach) and there's hedonic hunger, eating for reward, habit or emotion. Wegovy tends to dull the hedonic pull more noticeably for many people, which is why emotional eating patterns shift differently from straightforward appetite. If you're still eating out of boredom or stress rather than physical need, that's a separate thread worth addressing alongside treatment.

Dose is also a significant variable. The STEP 1 trial published in the New England Journal of Medicine found an average 15% body weight reduction at 68 weeks on the 2.4mg dose, results that reflect a population average, not every individual's experience. The titration ladder exists precisely because response varies.

If you're finding hunger persistent at a given dose, our page covering whether you still get hungry on Wegovy addresses this in more detail, though the right conversation about your own dosing is always with your prescriber, not the internet. Timing of the injection, protein intake, sleep and stress all interact with how appetite signals land.

What to eat when hunger is still there

Food choices matter more, not less, when appetite is reduced. A smaller stomach capacity means less room for nutrients, and the most common dietary problem on Wegovy isn't overeating, it's under-eating protein and skimping on vegetables because a handful of crackers satisfied the hunger signal.

Our Wegovy food guide goes into this properly, but the short version is: prioritise protein at each meal (it maintains muscle and extends the feeling of fullness), keep fibre coming in through vegetables and legumes, and stay well hydrated. GI side effects (nausea, constipation) are easier to manage on a diet built around whole foods than on ultra-processed ones, even if those are what you fancy when your appetite is low.

It's also worth knowing that if hunger returns sharply a few days before your next injection is due, that's a recognised pattern. Semaglutide's half-life means levels dip in the days before the next dose. Some people find adjusting when in the week they inject (always the same day, as instructed) helps maintain more even coverage, but any change to your schedule is a conversation for your prescriber, not something to adjust unilaterally.

If you're still working out how Wegovy fits your situation, the free consultation at nume starts that conversation properly. A real clinician reads your answers the same day, not automated software. For a broader view of what's available, our weight-loss treatment overview covers the options.

Curious about how the UK private cost compares? This page walks through Wegovy pricing context without any surprises.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions